TCT 451: Potential Reduction of False Positive STEMI Activations by an Artificial Intelligence ECG Model 

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Boston Scientific Corporation; Cordis Corporation, a Johnson & Johnson company; Edwards Lifesciences; Medtronic; Opsens; Philips; Siemens Healthineers</li></ul>